![]() |
![]() |
|
|
Acoustic NeuromaWhat treatments are available for acoustic neuroma? The Ear Institute of Chicago experience with acoustic neuroma
|
||||||||||||||||||||||||||||||||||||||
![]() |
| Small acoustic neuroma in the internal auditory canal. |
Acoustic neuromas commonly develop inside the internal auditory canal. These tumors usually grow slowly over a period of many years. When acoustic neuromas grow in size, the tumor compresses the hearing nerve. Therefore, hearing loss is the first symptom in over 90% of patients with acoustic neuroma. Tinnitus or ear noise is also a common symptom. Loss of balance, dizziness or facial weakness may develop as the tumor continues to grow.
With appropriate tests it is now possible to identify tumors as small
as 1-3mm in size. The first step in identifying a possible tumor
is a thorough history and physical examination by a physician. Hearing
testing is performed to identify any loss of hearing or speech understanding.
An auditory brainstem response test (abbreviated ABR, BAER, or BSER)
is ordered if there are any asymmetries in hearing testing between
the right and left ears. An ABR provides information on the passage
of an electrical impulse along the hearing nerve from the ear to
the brain. Abnormal ABR results suggest a poorly functioning hearing
nerve. A detailed "imaging" is ordered if there is an abnormality
of the ABR test.
The most accurate imaging technique for acoustic neuroma identification is a magnetic resonance imaging (MRI). A properly performed MRI can identify acoustic neuromas as small as 2-3mm. MRI uses magnetic pulses and radio frequency waves to produce an image of a portion of the body being studied. Radiation is not used to perform an MRI. A contrast material, gadolinium, is given during the MRI to enhance the visibility of the tumor.
Observation
Since acoustic neuromas are benign, often slow-growing tumors, careful
observation over a period of time may be appropriate for some patients.
When a small tumor is discovered in an older patient, observation to study
the growth rate of the tumor may be indicated if acute symptoms are not
present. A MRI scan of the tumor and surrounding region must be performed
periodically to determine if there is any significant change in the
size of the tumor. If the tumor does not grow, observation is continued.
If the tumor increases in size, treatment may be recommended.
Surgical Removal
There are several surgical approaches that may be used to remove an acoustic
tumor. The type of approach is individualized depending on the patient's
wishes, hearing level, other neurological symptoms, and location and size
of the tumor. The Ear Institute of Chicago, LLC is well versed in all surgical
approaches for acoustic neuroma management.
Middle Fossa Approach
In the middle fossa approach, the bone is opened above the ear and the bone
overlying the tumor is removed. The inner ear is not entered. Therefore,
hearing preservation is possible. The middle fossa approach is most suitable
for small tumors with good hearing.
Retrosigmoid Approach
In this approach, the bone is opened behind both the mastoid bone and the
inner ear. In this way the tumor is removed from behind the inner ear. Retrosigmoid
removal also allows the possibility of hearing preservation and may be used
for both small and large tumors.
Translabyrinthine Approach
In the translabyrinthine approach, the mastoid bone behind the ear is removed
and the inner ear is opened. This exposes the internal auditory canal directly.
All hearing is lost with this approach. The translabyrinthine approach is,
therefore, used only for those cases where hearing loss is already severe
or the tumor is so large that hearing conservation is not a realistic goal.
Hospital stay after any type of microsurgery ranges from 4-7 days. Approximately
4-6 weeks is suggested for recovery.
back to the top
Stereotactic Radiation Therapy
Stereotactic radiation therapy, which is commonly known as "radiosurgery," is
a single session radiation treatment. Using computer imaging, a single,
high dose of radiation is delivered to the acoustic tumor while minimizing
injury to surrounding nerves and brain tissue. Treatment is often
performed on an outpatient basis.
Stereotactic radiation prevents further tumor growth and sometimes shrinks
a portion of the tumor. This type of treatment does not remove the tumor.
Follow-up imaging studies are important because some tumors will continue
to grow after stereotactic radiation. For more information regarding Stereotactic Radiation Therapy, please click here.
Each form of acoustic neuroma treatment, either surgery or radiation, has
advantages and disadvantages. Many factors are used to determine the most
appropriate type of treatment.
The Ear Institute of Chicago, LLC has a combined experience with over 1000
patients with acoustic neuroma during a 20-year period. This makes the Ear
Institute of Chicago, LLC one of the largest acoustic neuroma centers in
the United States.
The group is well versed in all aspects of management of acoustic
neuromas. The physicians are capable of performing all surgical
approaches for acoustic neuroma removal, including the translabyrinthine,
retrosigmoid, and middle fossa approaches. A wait and see approach
is also used in selected cases depending on symptoms and the
size/location of the tumor.
The type of management is individualized depending on the patient's wishes,
hearing level, other neurological symptoms, and location and size of
the tumor. The final choice is one that will provide the most ethical
outcome.
The Ear Institute of Chicago, LLC maintains an outcome database based
on the treatment of over 1000 patients with acoustic neuroma during the
past 15 years. The database is used to improve treatment techniques by
evaluating the group's microsurgical outcomes.
Acoustic neuroma research is a large part of the practice of the Ear
Institute of Chicago. The group is currently working with Northwestern
Memorial Hospital to evaluate several disease specific issues regarding
acoustic neuromas. These issues include the epidemiology, the genetics,
and the molecular biology of acoustic neuromas. The ultimate goal of
this study is to determine the factors that lead to the best management
of a patient with an acoustic neuroma.
The following tables summarize the acoustic neuroma operative experience
and results of the Ear Institute of Chicago from 1982 - 1998 (updated
August 1998):
Table 1. Ear Institute of Chicago
operative approach for acoustic neuroma from 1982 -1998. |
|
Table 3. Facial nerve function after translabyrinthine approach. Facial nerve results are documented 12 months or longer after surgery. Results are for tumors of all sizes. (House-Brackmann facial nerve grade: grade I = normal movement, grade VI = no facial movement) |